Testosterone Drugs May Boost Libidos, Fuel Profits

Testosterone Drugs May Boost Libidos, Fuel Profits Play

May 2 (Bloomberg) -- Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men who have low levels of testosterone. Doctors warn demand for the treatments could lead to overuse with deadly side effects. Bloomberg's Shannon Pettypiece reports. (Source: Bloomberg)

  • On Air Now

    Countdown Watch Now

  • Next

    On the Move with Rishaad Salamat

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus